KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT (2016 - 2025)

Medpace Holdings (MEDP) has disclosed EBT for 11 consecutive years, with $156.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 17.14% year-over-year to $156.8 million, compared with a TTM value of $542.4 million through Dec 2025, up 13.96%, and an annual FY2025 reading of $542.4 million, up 13.96% over the prior year.
  • EBT was $156.8 million for Q4 2025 at Medpace Holdings, up from $142.8 million in the prior quarter.
  • Across five years, EBT topped out at $156.8 million in Q4 2025 and bottomed at $42.4 million in Q2 2021.
  • Average EBT over 5 years is $91.9 million, with a median of $84.6 million recorded in 2023.
  • The sharpest move saw EBT soared 52.58% in 2022, then grew 1.6% in 2023.
  • Year by year, EBT stood at $55.9 million in 2021, then surged by 31.69% to $73.6 million in 2022, then grew by 23.17% to $90.7 million in 2023, then soared by 47.6% to $133.9 million in 2024, then rose by 17.14% to $156.8 million in 2025.
  • Business Quant data shows EBT for MEDP at $156.8 million in Q4 2025, $142.8 million in Q3 2025, and $124.5 million in Q2 2025.